Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Awaiting development
Awaiting development: Guidance and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Area of interest
Area of interest
COVID-19 (3)
Type
Type
Guidance (84)
Quality standard (3)
Guidance programme
Guidance programme
HealthTech guidance (8)
Technology appraisal guidance (76)
Apply filters
Showing 81 to 87 of 87
Keyword or reference number: in
`Remove $Keyword or reference number: in filter`
Guidance and quality standards awaiting development
Title
Type
Upadacitinib for treating moderate to severe hidradenitis suppurativa
in
people 12 years and over [ID6666]
Technology appraisal guidance
Venglustat for treating type 3 Gaucher disease
in
people aged 12 and over after at least 3 years of enzyme replacement therapy [ID6295]
Technology appraisal guidance
Vertebral body tethering for idiopathic scoliosis
in
children and young people
HealthTech guidance
Vosoritide for treating achondroplasia
in
children and young people under 18 years [ID3807]
Technology appraisal guidance
WP1048 for treating grass pollen allergy
in
people aged 18 to 60 [TSID10467]
Technology appraisal guidance
Zilurgisertib for preventing new heterotopic ossification lesions caused by fibrodysplasia ossificans progressiva
in
people 12 years and over [ID6637]
Technology appraisal guidance
Zimislecel for treating type 1 diabetes
in
people 12 years and over with impaired hypoglycaemic awareness and severe hypoglycaemia [ID6624]
Technology appraisal guidance
Previous page
1
…
7
8
Current page
9
Page
9
of
9
Results per page
10
25
50
All
Back to top